Pharmaceutical - Financial, Global

Filter

Current filters:

FinancialGlobal

Popular Filters

1 to 25 of 32 results

Big savings on HIV drugs via pooled procurement expected by Global Fund

Big savings on HIV drugs via pooled procurement expected by Global Fund

12-12-2014

The Global Fund to Fight AIDS, Tuberculosis and Malaria is putting into place a new agreement for purchasing…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalPricing

Cost of bringing new drug to market now around $2.6 billion, says Tufts CSDD

19-11-2014

Developing a new prescription medicine that gains marketing approval, a process often lasting longer…

FinancialGlobalPharmaceuticalResearch

IMS Health identifies 10 events that may transform the delivery of health care

IMS Health identifies 10 events that may transform the delivery of health care

23-09-2014

As the global market for drugs surpasses $1 trillion this year, growing payer scrutiny of value for money…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalRegulationResearchVaccines

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

20-08-2014

An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014…

FinancialGlobalJonathan GardnerMergers & AcquisitionsPharmaceutical

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

06-08-2014

‘Digital pharma’ is by no means a new concept for pharmaceutical marketers. But what is new is that…

FinancialGlobalMarkets & MarketingPharmaceutical

Private equity firms could be looking to acquire mature GSK and Sanofi brands

Private equity firms could be looking to acquire mature GSK and Sanofi brands

05-08-2014

Private equity groups KKR and Warburg Pincus are considering a $10 billion plan to buy drug brands from…

Business FinanceFinancialGlaxoSmithKlineGlobalMylanPharmaceuticalSanofi

Pharma more optimistic about future despite upcoming industry consolidation

Pharma more optimistic about future despite upcoming industry consolidation

13-06-2014

More than 69% of senior players within the pan-world pharma industry expect to see a year-on-year increase…

FinancialGlobalMergers & AcquisitionsPharmaceutical

Report shows rise in IPOs revive investments in pharma and biotech

Report shows rise in IPOs revive investments in pharma and biotech

29-05-2014

The heightened private equity and venture capital (PEVC) deal activity in the global health care industry…

BiotechnologyBusiness FinanceFinancialGlobalHealth Medical PharmaPharmaceuticalPharmaceutical industryPharmaceutical sciencesPrivate

Report: R&D market is diversifying innovation, with increased partnerships, mergers and revenue sharing models

06-03-2014

The R&D sector is set to grow at more than 8% driven by new evaluation techniques, according to CPhI…

FinancialGlobalPharmaceuticalResearch

New schizophrenia drug Abilify to lead the market by 2016

New schizophrenia drug Abilify to lead the market by 2016

29-12-2013

Long-acting depot therapy Abilify Maintena (aripiprazole) will become the leading injectable schizophrenia…

AbilifyAbilify MaintenaFinancialGlobalLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceutical

Report: Alzheimer’s Disease market to reach $3.8 billion in 2019

Report: Alzheimer’s Disease market to reach $3.8 billion in 2019

27-12-2013

The Alzheimer’s Disease (AD) market will increase slightly from $3.6 billion in 2012 to $3.8 billion…

FinancialGlobalMarkets & MarketingNeurologicalPharmaceuticalResearch

What will 2014 hold for pharma?

What will 2014 hold for pharma?

20-12-2013

We take a look at key trends for 2014.

FinancialGlobalMarkets & MarketingPharmaceutical

Lack understanding of the impact of global drug pricing on profits, finds Model N survey

10-12-2013

More than half (58%) of pharmaceutical companies believe the challenges of global drug pricing are not…

FinancialGlobalPharmaceuticalPricing

Health spending down in a third of OECD nations, as governments cut budgets

21-11-2013

Total health spending has fallen in one of three Organization for Economic Cooperation and Development…

FinancialGlobalHealthcarePharmaceutical

Baxter buys exclusive rights to CTI’s cancer drug pacritinib

18-11-2013

USA-based companies Baxter International and Cell Therapeutics have entered into an exclusive worldwide…

Baxter InternationalCell TherapeuticsFinancialGlobalLicensingOncologypacritinibPharmaceutical

Current profitability is a priority for 80% of pharma companies ahead of future

04-11-2013

Pharmaceutical companies are more concerned with getting their existing business right, before implementing…

FinancialGlobalPharmaceuticalResearch

Growing diabetes market will attract superior disease control

29-08-2013

The expected rise in diabetes is encouraging pharma companies to race to launch type 2 diabetes drugs,…

DiabetesFinancialGlobalPharmaceutical

Multiple sclerosis market could reach $18.3 billion in 2018

19-08-2013

The multiple sclerosis (MS) market is expected to peak at $18.3 billion in 2018, according to healthcare…

AubagioBiogen IdecFinancialGilenyaGlobalNovartisPharmaceuticalSanofiTecfidera

Rx drugs bulk buying may save governments money but poses a risk for some patients, says Canadian think-tank

14-05-2013

Governments that opt for prescription drug bulk-purchasing agreements can save taxpayers money but at…

FinancialGlobalHealthcarePharmaceutical

Europe falling behind USA and China as attractive for life sciences sector

22-04-2013

Intellectual property specialists Marks & Clerk's latest Life Sciences Report unveils the changing landscape…

BiotechnologyFinancialGlobalPatentsPharmaceuticalRegulationResearch

Revenue growth optimism in pharmaceutical industry: 2013 surveys report

20-02-2013

According to new global pharmaceutical industry surveys on buyer spend and procurement strategies, 55%…

FinancialGlobalMarkets & MarketingPharmaceutical

Responsible medicines use can avoid $500 billion in global health care costs, says IMS

02-10-2012

About $500 billion in global health care costs can be avoided annually through more responsible use of…

FinancialGenericsGlobalHealthcarePharmaceutical

Clinical trials due an overhaul to conquer the Pharma "Valley of Death"

30-09-2012

Costs associated with drug development have risen from around $138 million in 1975 to over $1 billion…

BiotechnologyFinancialGlobalPharmaceuticalResearch

Pharma vs the world: Big Pharma caught between investors and public

23-09-2012

Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

1 to 25 of 32 results

Back to top